FMP

FMP

Enter

PRTK - Paratek Pharmaceuticals, Inc.

Profile of Paratek Pharmaceuticals, Inc.(PRTK), Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the developm

photo-url-https://financialmodelingprep.com/image-stock/PRTK.png

Paratek Pharmaceuticals, Inc.

PRTK

NASDAQ

2.23 USD

0.04 (1.79%)

About

ceo

Dr. Evan Loh FACC, FAHA, M.D.

sector

Healthcare

industry

Biotechnology

website

https://paratekpharma.com

exchange

NASDAQ

Description

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.

CIK

0001178711

ISIN

US6993743029

CUSIP

699374302

Address

75 Park Plaza

Phone

617 807 6600

Country

US

Employee

268

IPO Date

Feb 3, 2009

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep